← FDA DRUG APPROVALS

FDA ANDA · ANDA040793

A-METHAPRED

Sponsor: HOSPIRA INC

APPLICATION
ANDA040793
TYPE
ANDA
ORIGINAL APPROVAL
2008-11-25
LATEST ACTION
2016-01-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

A-METHAPREDDiscontinued
METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2016-01-26Labeling · Supplement 5 · standardAP
2016-01-26Labeling · Supplement 4AP
2008-11-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →